VNDA

Vanda Pharmaceuticals Inc.

Last Updated:

Q3 '20

Price

quotes and stock data delayed 15 minutes

Cash

$348.5M

Burn Rate (Qtr)

-$5.9M

Company Profile

Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

HETLIOZ® (tasimelteon)

Smith-Magenis Syndrome (SMS)

PDUFA

December 1, 2020

Fanapt® (iloperidone)

Schizophrenia

Quarterly Sales (Approved)

January 2021

HETLIOZ® (tasimelteon)

Jet Lag Disorder

Report out on post-CRL FDA meeting

January 2021

HETLIOZ® (tasimelteon)

Non-24-Hour Sleep-Wake Disorder (Non-24)

Quarterly Sales (Approved)

January 2021

Tradipitant

Motion Sickness

Phase 3

TBD

Tradipitant | ODYSSEY VLY-686-3501

COVID-19

Phase 3 (Safety and Efficacy Data)

TBD

Tradipitant

Pruritus in Atopic Dermatitis | EPIONE

Phase 3

TBD

Tradipitant

Gastroparesis

NDA Filing

2021

Trichostatin A (VTR-297)

Relapsed or Refractory Hematologic Malignancies

Phase 1

TBD

Recent Posts

See what the community is saying - click to see full post

VNDA - Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results

Upcoming September 2020 COVID-19 Therapeutic Catalyst Event

VNDA - Interim Analysis from #ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon